Clearance of Aβ mediated by lrp-1 at the BBB has been suggested as a potential target for treatment and prevention of Aβ brain accumulation in Alzheimer’s disease [73], and therefore a better understanding of the lrp-1 expression at the BBB will help in optimizing such a therapeutic strategy. Here, LRP1 is linked to early-onset autosomal dominant Alzheimer disease.